BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23719333)

  • 1. Emerging therapies for sarcoma.
    Movva S
    Curr Probl Cancer; 2013; 37(2):87-101. PubMed ID: 23719333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soft tissue sarcomas: are all soft tissue sarcomas treated with the same drugs?
    Blay JY; Cassier PA; Ray-Coquard I
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S385-8. PubMed ID: 21944026
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
    Riedel RF
    Semin Oncol; 2011 Oct; 38 Suppl 3():S30-42. PubMed ID: 22055970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic pipeline for soft-tissue sarcoma.
    Cassier PA; Labidi-Galy SI; Heudel P; Dutour A; Méeus P; Chelghoum M; Alberti L; Ray-Coquard I; Blay JY
    Expert Opin Pharmacother; 2011 Nov; 12(16):2479-91. PubMed ID: 21913865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.
    Aragon-Ching JB; Maki RG
    Cancer Invest; 2012 May; 30(4):300-8. PubMed ID: 22480231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel treatment strategies for soft tissue sarcoma.
    Kasper B; Gil T; D'Hondt V; Gebhart M; Awada A
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):9-15. PubMed ID: 17141519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapies in soft tissue sarcoma.
    Vincenzi B; Frezza AM; Santini D; Tonini G
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):237-48. PubMed ID: 20465449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapy in bone and soft tissue sarcoma in children and adolescents.
    Thompson PA; Chintagumpala M
    Curr Oncol Rep; 2012 Apr; 14(2):197-205. PubMed ID: 22302601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of « druggable » alterations by histological subtypes of sarcomas and connective tissue intermediate malignancies.
    Penel N; Lebellec L; Blay JY; Robin YM
    Crit Rev Oncol Hematol; 2020 Jun; 150():102960. PubMed ID: 32320927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New emerging drugs in soft tissue sarcoma.
    Milano A; Apice G; Ferrari E; Fazioli F; de Rosa V; de Luna AS; Iaffaioli RV; Caponigro F
    Crit Rev Oncol Hematol; 2006 Jul; 59(1):74-84. PubMed ID: 16533604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma.
    Harwood JL; Alexander JH; Mayerson JL; Scharschmidt TJ
    Orthop Clin North Am; 2015 Oct; 46(4):587-608. PubMed ID: 26410647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma.
    Wisdom AJ; Mowery YM; Riedel RF; Kirsch DG
    Cancer; 2018 Oct; 124(19):3819-3829. PubMed ID: 29723407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New targets for therapy of sarcoma.
    Magenau JM; Schuetze SM
    Curr Opin Oncol; 2008 Jul; 20(4):400-6. PubMed ID: 18525335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pazopanib in the treatment of soft tissue sarcoma.
    Schöffski P
    Expert Rev Anticancer Ther; 2012 Jun; 12(6):711-23. PubMed ID: 22716487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of mTOR inhibitors for treatment of sarcomas.
    Mita MM; Tolcher AW
    Curr Oncol Rep; 2007 Jul; 9(4):316-22. PubMed ID: 17588357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for pediatric soft-tissue sarcomas.
    Casanova M; Ferrari A
    Expert Opin Pharmacother; 2011 Mar; 12(4):517-31. PubMed ID: 21306288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of chemotherapy in patients with soft tissue sarcomas.
    Maki RG
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):229-36. PubMed ID: 15056053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pathways and molecular targets for the treatment of sarcoma.
    Frith AE; Hirbe AC; Van Tine BA
    Curr Oncol Rep; 2013 Aug; 15(4):378-85. PubMed ID: 23661264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Targeted therapies in soft-tissue and visceral sarcomas].
    Emile JF
    Ann Pathol; 2009 Nov; 29 Spec No 1():S81-2. PubMed ID: 19887262
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted therapies for soft-tissue sarcomas.
    Tap WD; Federman N; Eilber FC
    Expert Rev Anticancer Ther; 2007 May; 7(5):725-33. PubMed ID: 17492935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.